Biotest AG (ETR:BIO)

PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 7 months ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF

published on 02/28/2024 at 10:00, 2 years 7 months ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/14/2024 at 08:30, 2 years 7 months ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years 10 months ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 2 years 10 months ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 2 years 11 months ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 2 years 11 months ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE

published on 09/21/2023 at 09:00, 3 years ago

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE

published on 09/12/2023 at 09:00, 3 years ago

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE

published on 09/07/2023 at 09:00, 3 years ago

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo

Published on 09/28/2026 at 13:30, 24 minutes ago

Menē Inc. Announces Normal Course Issuer Bid
Published on 09/28/2026 at 13:30, 24 minutes ago

Nextech3D.ai Announces CEO Evan Gappelberg Acquires 7.4 Million Shares
Published on 09/28/2026 at 13:00, 54 minutes ago

Fermi Selects NAES to Operate and Maintain Its Natural Gas Turbine Fleet
Published on 09/28/2026 at 13:00, 54 minutes ago

Grid Metals to Participate in Upcoming Investor Conferences
Published on 09/28/2026 at 13:00, 54 minutes ago

Irving Advances the Unoya Target at Its Shika Epithermal Au-Ag Project, Noto Peninsula, Honshu, Japan through Systematic Geological, Geochemical and Geophysical Work

View all ACCESSWIRE

Published on 09/28/2026 at 13:48, 5 minutes ago

EQS-Adhoc: Redcare Pharmacy raises again full-year 2026 revenue guidance driven by strong Rx momentum in Germany
Published on 09/28/2026 at 12:30, 1 hour 24 minutes ago

Viromed Medical AG advances product development and market launch in the first half of 2026 and confirms full-year guidance
Published on 09/28/2026 at 11:18, 2 hours 35 minutes ago

POS-Transaction in Own Shares
Published on 09/28/2026 at 11:00, 2 hours 54 minutes ago

HEIG-VD and Romande Energie working more closely together to promote innovation and the green transition
Published on 09/28/2026 at 10:15, 3 hours 38 minutes ago

EQS-Adhoc: AGRANA Beteiligungs-Aktiengesellschaft: AGRANA raises EBIT forecast for 2026|27 financial year

View all EQS

Published on 09/28/2026 at 08:45, 5 hours 9 minutes ago

BAIKOWSKI: 2026 first-half results
Published on 09/28/2026 at 08:02, 5 hours 52 minutes ago

Saint-Gobain signs renewable electricity purchase agreement in the United Kingdom
Published on 09/25/2026 at 17:40, 2 days 20 hours ago

Availability of the 2026 half-year financial report
Published on 09/24/2026 at 18:10, 3 days 19 hours ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 3 days 19 hours ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026

View all LES ECHOS COMFI WIRE

News